NIH accepting comments through May 26 on serology research priorities
The National Cancer Institute and National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, seek through May 26 on research priorities for COVID-19 serology testing and related technologies, which are key to understanding immunity and developing vaccines against the virus.
The Paycheck Protection Program and Health Care Enhancement Act provides $306 million to NIH to develop, validate, improve and implement serological testing and associated technologies.
The agency intends to applications for funding to establish Serological Sciences Centers of Excellence and projects to advance research on immune responses to the SARS-CoV-2 virus, including how it relates to cancer patients.
Related News Articles
Headline
A study published April 8 by the Public Library of Science’s Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of…
Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.’s nomination for secretary of the Department of Health and Human Services. A…
Headline
Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease Control and Prevention. Seasonal flu…
Headline
The Occupational Safety and Health Administration Jan. 13 announced that it terminated efforts to establish a final COVID-19 safety standard to protect workers…
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…